Strickler JH, Raimbourg J, Cohen JE, Ghiringhelli F, et al. Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer. Clin Cancer Res 2026;32:2352-2361.
PMID: 41910595